login

Shortened survival in infants vertically infected with human immunodeficiency virus with elevated p24 antigenemia

The Journal of PediatricsPublished 1 October 1995
Nina Arlievsky, Henry Pollack, Mona Rigaud, Aditya Kaul, Keith Krasinski, William Borkowsky
Citations18
SJR quartileQ1
SJR score1.01
SNIP1.11

TL;DR

Elevated p24 antigenemia in the first 6 months of life is associated with shorter survival and may be a useful predictor of outcome.

Abstract

Elevated p24 antigenemia in the first 6 months of life is associated with shorter survival and may be a useful predictor of outcome.

Keywords

Immunology and MicrobiologyMedicine